Effects of elastase inhibitor on the epithelial cell apoptosis in bleomycin-induced pulmonary fibrosis

Experimental Lung Research

Volumn 35, Issue 10, 2009, Pages 817-829

  Song, Jeong Sup ^a   Kang, Chun Mi ^a   Rhee, Chin Kook ^a   Yoon, Hyung Kyu ^a   Kim, Young Kyoon ^b   Moon, Hwa Sik ^b   Park, Sung Hak ^b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Apoptosis; Elastase inhibitor; Pulmonary fibrosis

Indexed keywords

BLEOMYCIN; CASPASE 3; CASPASE 9; CYTOCHROME C; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; ELASTASE INHIBITOR; SIVELESTAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVITY; EPITHELIUM CELL; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; LUNG FIBROSIS; LUNG LAVAGE; MALE; MITOCHONDRION; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; CASPASE 3; CASPASE 9; CELL LINE; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; EPITHELIAL CELLS; GLYCINE; HUMANS; HYDROXYPROLINE; LEUKOCYTE ELASTASE; LUNG; MALE; NEUTROPHILS; POLY(ADP-RIBOSE) POLYMERASES; PULMONARY FIBROSIS; RATS; RATS, SPRAGUE-DAWLEY; SERINE PROTEINASE INHIBITORS; SULFONAMIDES;

EID: 72049131567     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902140902912527     Document Type: Article

References (35)

1. Golan-Gerstl R, Wallach-Dayan SB, Amir G, Breuer R: Epithelial cell apoptosis by fas ligand-positive myofibroblasts in lung fibrosis. Am J Respir Cell Mol Biol. 2007;36:270-275. (Pubitemid 46365277)
2. Gross TJ, Hunninghake GW: Idiopathic pulmonary fibrosis. N Engl J Med. 2001;345:517-525.
3. Plataki M, Koutsopoulos AV, Darivianaki K, Delides G, Siafakas NM, Bouros D: Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis. Chest 2005;127:266-274.
4. Wallach-Dayan SB, Izbicki G, Cohen PY, Gerstl-Golan R, Fine A, Breuer R: Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathway. Am J Physiol Lung Cell Mol Physiol. 2006;290:L790-L796.
5. Ginzberg HH, Shannon PT, Suzuki T, Hong O, Vachon E, Moraes T, Abreu MT, Cherepanov V, Wang X, Chow CW, Downey GP: Leukocyte elastase induces epithelial apoptosis: role of mitochondial permeability changes and Akt. Am J Physiol Gastrointest Liver Physiol. 2004;287:G286-G298.
6. HagimotoN, Kuwano K,Nomoto Y, Kunitake R,HaraN: Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Cell Mol Biol. 1997;16:91-101. (Pubitemid 127497440)
7. Kuwano K, Hagimoto N, Kawasaki M, Yatomi T, Nakamura N, Nagata S, Suda T, Kunitake R, Maeyama T, Miyazaki H, Hara N: Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J Clin Invest. 1999;104:13-19.
8. SelmanM, Pardo A: The epithelial/fibroblastic pathway in the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol. 2003;29(3 Suppl):S93-S97. (Pubitemid 37070317)
9. Nagai A, Aoshiba K, Ishihara Y, Inano H, Sakamoto K, Yamaguchi E, Kagawa J, Takizawa T: Administration of alpha 1-proteinase inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters. Am Rev Respir Dis. 1992;145:651-656.
10. Chua F, Dunsmore SE, Clingen PH, Mutsaers SE, Shapiro SD, Segal AW, Roes J, Laurent GJ: Mice lacking neutrophil elastase are resistant to bleomycin-induced pulmonary fibrosis. Am J Pathol. 2007;170:65-74.
11. Taooka Y, Maeda A, Hiyama K, Ishioka S, Yamakido M: Effects of neutrophil elastase inhibitor on bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med. 1997;156:260-265.
12. Pradella L: ONO-5046 (Ono Pharmaceutical). Drugs 2000;3:208-222.
13. Petrache I, Fijalkowska I, Medler TR, Skirball J, Cruz P, Zhen L, Petrache HI, Flotte TR, Tuder RM: Alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am J Pathol. 2006;169:1155-1166.
14. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493-501.
15. Cleutjens JP, Verluyten MJ, Smiths JF, DaemenMJ: Collagen remodeling aftermyocardial infarction in the rat heart. Am J Pathol. 1995;147:325-338.
16. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63.
17. Lee VY, Schroedl C, Brunelle JK, Buccellato LJ, AkinciOI, Kaneto H, Snyder C, Eisenbart J, Budinger GR,Chandel NS: Bleomycin induces alveolar epithelial cell death through JNK-dependent activation of the mitochondrial death pathway. Am J physiol Lung Cell Mol Physiol. 2005;289:L521-L528.
18. Hamilton RF Jr, Li L, Felder TB, Holian A: Bleomycin induces apoptosis in human alveolar macrophages. Am J Physiol Lung Cell Mol Physiol. 1995;269(3 Pt 1):L318-L325.
19. Chapman HA: A Fas pathway to pulmonary fibrosis. J Clin Invest. 1999;104:1-2.
20. Shen AS, Haslett C, Feldsien DC, Henson PM, Cherniack RM: The intensity of chronic lung inflammation and fibrosis after bleomycin is directly related to the severity of acute injury. Am Rev Respir Dis. 1988;137:564-571.
21. Kawabata K, Suzuki M, Sugitani M, Imaki K, Toda M, Miyamoto T: ONO-5046, a novel inhibitor of human neutrophil elastase. Biochem Biophys Res Commun. 1991;177:814-820.
22. Schroder JM,Mrowietz U,Morita E, Christophers E: Purification and partial biochemical characterization of a humanmonocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. J Immunol. 1987;139:3474-3483.
23. Ziegenhagen MW, Zabel P, Zissel G, Schlaak M, Muller-Quernheim J: Serum level of interleukin 8 is elevated in idiopathic pulmonary fibrosis and indicates disease activity. Am J Respir Crit Care Med. 1998;157(3 Pt 1):762-768.
24. Uhal BD, Joshi I, Hughes WF, Ramos C, Pardo A, Selman M: Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am J Physiol Lung Cell Mol Physiol. 1998;275(6 Pt 1):L1192-L1199.
25. Kuwano K, Miyazaki H, Hagimoto N, Kawasaki M, Fujita M, Kunitake R, Kaneko Y, Hara N: The involvement of Fas-Fas ligand pathway in fibrosing lung diseases. Am J Respir Cell Mol Biol. 1999;20:53-60.
26. Lu Q, Harrington EO, Rounds S: Apoptosis and lung injury. Keio J Med. 2005;54:184-189.
27. Ashkenazi A, Dixit VM: Death receptors: signaling and modulation. Science 1998;281:1305-1308.
28. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X: Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol. 1999;15:269-290.
29. Suzuki T, Moraes TJ, Vachon E, Ginzberg HH, Huang TT, Matthay MA, Hollenberg MD, Marshall J, McCulloch CA, AbreuMT, Chow CW,DowneyGP: Proteinase-activated receptor-1mediates elastaseinduced apoptosis of human lung epithelial cells. Am J Respir Cell Mol Biol. 2005;33:231-247.
30. Szabo C, Dawson VL: Role of poly(ADP-ribose) synthetase in inflammation and ischaemiareperfusion. Trends Pharmacol Sci. 1998;19:287-298.
31. Cosi C, Marien M: Implication of poly (ADP-ribose) polymerase (PARP) in neurodegeneration and brain energymetabolism. Decreases inmouse brain NAD+ and ATP caused by MPTP are prevented by the PARP inhibitor benzamide. Ann N Y Acad Sci. 1999;890:227-239.
32. Genovese T, Mazzon E, Di Paola R, Muia C, Threadgill MD, Caputi AP, Thiemermann C, Cuzzocrea S: Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and the development of bleomycin-induced lung injury. J Pharmacol Exp Ther. 2005;313:529-538. (Pubitemid 40604151)
33. Cuzzocrea S, Genovese T, Failla M, Vecchio G, Fruciano M, Mazzon E, Di Paola R, Muia C, La Rosa C, Crimi N, Rizzarelli E, Vancheri C. Protective effect of orally administered carnosine on bleomycin-induced lung injury. Am J Physiol Lung Cell Mol Physiol. 2007;292:L1095-L1104.
34. Kuwano K, Hagimoto N, Maeyama T, Fujita M, Yoshimi M, Inoshima I, Nakashima N, Hamada N, Watanabe K, Hara N: Mitochondria-mediated apoptosis of lung epithelial cells in idiopathic interstitial pneumonias. Lab Invest. 2002;82:1695-1706. (Pubitemid 35462982)
35. Budinger GR, Mutlu GM, Eisenbart J, Fuller AC, Bellmeyer AA, Baker CM, Wilson M, Ridge K, Barrett TA, Lee VY, Chandel NS: Proapoptotic Bid is required for pulmonary fibrosis. Proc Natl Acad Sci USA 2006;103:4604-4609.